type 2 diabetes mellitus; diabetes mellitus type 2; diabetes mellitus type II; type 2 diabetes; type 2 DM; T2DM; T2D; type 2 diabetes mellitus (T2DM); type 2 diabetes (T2D)

GLP-1s Reduce Cardiovascular and Alzheimer’s Disease Risks Associated with Type 2 Diabetes

by

GLP-1 Receptor Agonists Show Promise in reducing Cardiovascular Risk for Patients with Diabetes and Skin Condition August 22, 2025 – 8:00 AM Breaking News: GLP-1 Receptor Agonists Linked to Lower … Read More

Diabetes & Nerve Damage: Low FT3 a Key Risk Factor

by

Could Your Thyroid Levels Be Protecting You From Diabetic Nerve Damage? New Research Suggests a Link For the millions living with type 2 diabetes, the threat of diabetic peripheral neuropathy … Read More

GLP-1 Medications: Are You Getting the Right Treatment?

by

This article discusses vital considerations for managing patients on GLP-1 receptor agonists, a class of drugs used for weight management and treating type 2 diabetes. Here’s a breakdown of the … Read More

Beyond GLP-1s: A Holistic Approach to Weight Management Through Diet and Exercise

by

This article provides comprehensive guidance for clinicians on managing patients who are prescribed GLP-1 medications for weight loss. here’s a breakdown of the key recommendations: Calorie Intake and Diet: Individualized … Read More

GLP-1 Success: Factors for Weight Loss & Better Health

by

Beyond Ozempic: How Personalized GLP-1 Strategies Are Rewriting the Rules of Weight Loss For millions grappling with obesity, GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) have emerged as a beacon … Read More

Tirzepatide vs Semaglutide: Better T2D Control?

by

Tirzepatide’s Edge in Type 2 Diabetes: A Shift Towards Comprehensive Metabolic Control For millions battling type 2 diabetes (T2D), simply lowering blood sugar isn’t enough. A new analysis of the … Read More

GLP-1 Receptor Agonists: A Shield Against Stroke and Neurodegeneration?

by

Landmark Study Reveals GLP-1 Drugs dramatically Slash Dementia and Stroke Risk in Diabetics with Obesity Table of Contents 1. Landmark Study Reveals GLP-1 Drugs dramatically Slash Dementia and Stroke Risk … Read More

Cardiovascular Disease and Obesity: A Combined Risk Factor for Breast Cancer

by

This article discusses research on the association between body weight, cardiovascular disease (CVD), type 2 diabetes, and breast cancer risk in postmenopausal women. Here’s a breakdown of the key findings … Read More

Orforglipron for Type 2 Diabetes: Lowers A1c & Weight

by

The Future of Diabetes Treatment: Oral GLP-1 Agonists Are Set to Revolutionize Care Forget the needle – a new era in diabetes management is dawning. For years, the most effective … Read More

Water vs. Diet Soda: Can It Boost Diabetes Remission?

by

Water vs. Diet Drinks: The Unexpected Ally in Diabetes Remission and Weight Management Did you know that simply swapping your diet soda for water could nearly double your chances of … Read More